A Manufacturer’s Guide to Critical Drug Pricing and Reimbursement Considerations when Launching New Products

March 21, 2024 4:00pm

Sharon Small
Director, Counsel – Market Access-Gov.t Pricing and Policy
Novartis

Rujul H. Desai
Partner
Covington & Burling LLP

  • Examining pricing and reimbursement considerations form the pre-commercialization through product launch stages
  • Analyzing the procedural approaches to set a launch price for a new drug
  • Understanding legal, policy, and reputational risks around price setting
  • Ensuring transparency for the pricing process
  • Considering the role of traditional and non-traditional functions in setting price
  • Accessing government and commercial programs to secure appropriate coding, coverage, and reimbursement for new products
  • Examining how the IRA is impacting the pricing of new products